The drug nimodipine could prevent nerve cells from dying after brain surgery. Pharmacists at Martin Luther University Halle-Wittenberg (MLU), in cooperation with neurosurgeons at University Hospital Halle (Saale) (UKH), have developed a new method that enables the drug to be administered directly in the brain with fewer side effects. Their findings were published in the “European Journal of Pharmaceutics and Biopharmaceutics”.
- Injections are two-and-a-half times safer when nurses use revamped guidelines
- Cell ‘membrane on a chip’ could speed up screening of drug candidates for COVID-19
- Asthma does not seem to increase the severity of COVID-19
- Flashes bright when squeezed tight: How single-celled organisms light up the oceans
- Study indicates that Medicaid expansion has led to earlier cancer detection among individuals with low income